Matches in SemOpenAlex for { <https://semopenalex.org/work/W2951014781> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2951014781 endingPage "10" @default.
- W2951014781 startingPage "1" @default.
- W2951014781 abstract "The aberrant expression of Eya2 has been observed in a wide range of cancer types. However, the clinical significance and biological effects of EYA2 in human prostate cancer remain unknown. In this study, we showed that increased levels of Eya2 protein correlated with advanced TNM stage, T stage, and a higher Gleason score. Data from the Cancer Genome Atlas (TCGA) prostate cohort consistently revealed that Eya2 mRNA was positively correlated with a higher Gleason score, higher T stage, and positive nodal metastasis in prostate cancer. Furthermore, data from the Oncomine database showed increased levels of EYA2 mRNA expression in prostate cancer tissues compared with normal tissues. Eya2 protein expression was also higher in prostate cancer cell lines compared with a normal RWPE-1 cell line. We selected LNCaP and PC-3 cell lines for plasmid overexpression and shRNA knockdown. CCK-8, colony formation, and Matrigel invasion assays demonstrated that the overexpression of Eya2 promoted proliferation, colony number, and invasion while Eya2 shRNA inhibited proliferation rate, colony formation, and invasion ability. CCK-8 and Annexin V assays showed that Eya2 reduced sensitivity to docetaxel and docetaxel-induced apoptosis while Eya2 shRNA showed the opposite effects. The overexpression of Eya2 also downregulated the cleavage of caspase3 and PARP while Eya2 depletion upregulated caspase3 and PARP cleavage. Notably, JC-1 staining demonstrated that Eya2 upregulated mitochondrial membrane potential. We further revealed that the overexpression of Eya2 upregulated Bcl-2, matrix metalloproteinase 7 (MMP7), and AKT phosphorylation. Accordingly, data from the TCGA prostate cohort indicated that EYA2 mRNA was positively correlated with the expression of Bcl-2 and MMP7. The inhibition of AKT attenuated EYA2-induced Bcl-2 upregulation. In conclusion, our data demonstrated that Eya2 was upregulated in prostate cancers. EYA2 promotes cell proliferation and invasion as well as cancer progression by regulating docetaxel sensitivity and mitochondrial membrane potential, possibly via the AKT/Bcl-2 axis." @default.
- W2951014781 created "2019-06-27" @default.
- W2951014781 creator A5025203191 @default.
- W2951014781 creator A5045926855 @default.
- W2951014781 creator A5085186151 @default.
- W2951014781 date "2019-06-16" @default.
- W2951014781 modified "2023-10-14" @default.
- W2951014781 title "Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling" @default.
- W2951014781 cites W1767798659 @default.
- W2951014781 cites W1975375715 @default.
- W2951014781 cites W1984125069 @default.
- W2951014781 cites W2015536907 @default.
- W2951014781 cites W2017819409 @default.
- W2951014781 cites W2020579083 @default.
- W2951014781 cites W2021395106 @default.
- W2951014781 cites W2057271103 @default.
- W2951014781 cites W2071917878 @default.
- W2951014781 cites W2080356582 @default.
- W2951014781 cites W2108494968 @default.
- W2951014781 cites W2110675259 @default.
- W2951014781 cites W2120701638 @default.
- W2951014781 cites W2140408509 @default.
- W2951014781 cites W2169085459 @default.
- W2951014781 cites W2516958665 @default.
- W2951014781 cites W2570618306 @default.
- W2951014781 cites W2580400431 @default.
- W2951014781 cites W2607245627 @default.
- W2951014781 cites W2754660111 @default.
- W2951014781 cites W2772197679 @default.
- W2951014781 cites W2911441035 @default.
- W2951014781 cites W585352736 @default.
- W2951014781 doi "https://doi.org/10.1155/2019/3808432" @default.
- W2951014781 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6601494" @default.
- W2951014781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31317026" @default.
- W2951014781 hasPublicationYear "2019" @default.
- W2951014781 type Work @default.
- W2951014781 sameAs 2951014781 @default.
- W2951014781 citedByCount "5" @default.
- W2951014781 countsByYear W29510147812021 @default.
- W2951014781 countsByYear W29510147812022 @default.
- W2951014781 countsByYear W29510147812023 @default.
- W2951014781 crossrefType "journal-article" @default.
- W2951014781 hasAuthorship W2951014781A5025203191 @default.
- W2951014781 hasAuthorship W2951014781A5045926855 @default.
- W2951014781 hasAuthorship W2951014781A5085186151 @default.
- W2951014781 hasBestOaLocation W29510147811 @default.
- W2951014781 hasConcept C121608353 @default.
- W2951014781 hasConcept C126322002 @default.
- W2951014781 hasConcept C2779723316 @default.
- W2951014781 hasConcept C2780192828 @default.
- W2951014781 hasConcept C2781190966 @default.
- W2951014781 hasConcept C502942594 @default.
- W2951014781 hasConcept C62478195 @default.
- W2951014781 hasConcept C71924100 @default.
- W2951014781 hasConcept C75217442 @default.
- W2951014781 hasConcept C86803240 @default.
- W2951014781 hasConcept C95444343 @default.
- W2951014781 hasConceptScore W2951014781C121608353 @default.
- W2951014781 hasConceptScore W2951014781C126322002 @default.
- W2951014781 hasConceptScore W2951014781C2779723316 @default.
- W2951014781 hasConceptScore W2951014781C2780192828 @default.
- W2951014781 hasConceptScore W2951014781C2781190966 @default.
- W2951014781 hasConceptScore W2951014781C502942594 @default.
- W2951014781 hasConceptScore W2951014781C62478195 @default.
- W2951014781 hasConceptScore W2951014781C71924100 @default.
- W2951014781 hasConceptScore W2951014781C75217442 @default.
- W2951014781 hasConceptScore W2951014781C86803240 @default.
- W2951014781 hasConceptScore W2951014781C95444343 @default.
- W2951014781 hasLocation W29510147811 @default.
- W2951014781 hasLocation W29510147812 @default.
- W2951014781 hasLocation W29510147813 @default.
- W2951014781 hasLocation W29510147814 @default.
- W2951014781 hasOpenAccess W2951014781 @default.
- W2951014781 hasPrimaryLocation W29510147811 @default.
- W2951014781 hasRelatedWork W1588138630 @default.
- W2951014781 hasRelatedWork W1606861223 @default.
- W2951014781 hasRelatedWork W2014434161 @default.
- W2951014781 hasRelatedWork W2036273299 @default.
- W2951014781 hasRelatedWork W2118642421 @default.
- W2951014781 hasRelatedWork W2139216034 @default.
- W2951014781 hasRelatedWork W2945758293 @default.
- W2951014781 hasRelatedWork W3029943003 @default.
- W2951014781 hasRelatedWork W3038513643 @default.
- W2951014781 hasRelatedWork W3138747339 @default.
- W2951014781 hasVolume "2019" @default.
- W2951014781 isParatext "false" @default.
- W2951014781 isRetracted "false" @default.
- W2951014781 magId "2951014781" @default.
- W2951014781 workType "article" @default.